Peter Bryden

1.7k total citations · 1 hit paper
19 papers, 1.2k citations indexed

About

Peter Bryden is a scholar working on Clinical Psychology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Bryden has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Clinical Psychology, 3 papers in Genetics and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Bryden's work include Obsessive-Compulsive Spectrum Disorders (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Peter Bryden is often cited by papers focused on Obsessive-Compulsive Spectrum Disorders (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Peter Bryden collaborates with scholars based in United Kingdom, United States and Canada. Peter Bryden's co-authors include Nicky J. Welton, William Hollingworth, Deborah M Caldwell, Reecha Sofat, Jonathan A C Sterne, Aroon D. Hingorani, Philippa Davies, Julian P. T. Higgins, Diane Eaton and George N. Okoli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and BMJ.

In The Last Decade

Peter Bryden

17 papers receiving 1.1k citations

Hit Papers

Oral anticoagulants for prevention of stroke in atrial fi... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bryden United Kingdom 11 548 349 220 133 121 19 1.2k
Nelda Garcia United States 20 193 0.4× 55 0.2× 88 0.4× 45 0.3× 42 0.3× 60 1.5k
Patrizia Berto Italy 20 99 0.2× 57 0.2× 30 0.1× 24 0.2× 146 1.2× 74 1.1k
Victoria Y. Strauss United Kingdom 15 147 0.3× 147 0.4× 22 0.1× 46 0.3× 36 0.3× 50 957
Marta Sorribes Spain 15 185 0.3× 79 0.2× 85 0.4× 21 0.2× 32 0.3× 28 590
Lorenza Bertù Italy 14 141 0.3× 62 0.2× 99 0.5× 16 0.1× 8 0.1× 37 479
Jinseub Hwang South Korea 16 123 0.2× 74 0.2× 8 0.0× 94 0.7× 25 0.2× 71 1.1k
Florent Boutitie France 9 60 0.1× 115 0.3× 31 0.1× 19 0.1× 71 0.6× 19 748
Francis X. Solano United States 15 69 0.1× 93 0.3× 37 0.2× 21 0.2× 36 0.3× 26 907
T. Michelle Brown United States 17 64 0.1× 74 0.2× 17 0.1× 15 0.1× 63 0.5× 46 862
Kapil Parakh United States 19 999 1.8× 73 0.2× 32 0.1× 9 0.1× 37 0.3× 33 1.3k

Countries citing papers authored by Peter Bryden

Since Specialization
Citations

This map shows the geographic impact of Peter Bryden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bryden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bryden more than expected).

Fields of papers citing papers by Peter Bryden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bryden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bryden. The network helps show where Peter Bryden may publish in the future.

Co-authorship network of co-authors of Peter Bryden

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bryden. A scholar is included among the top collaborators of Peter Bryden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bryden. Peter Bryden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Skapinakis, Petros, Deborah M Caldwell, William Hollingworth, et al.. (2021). Pharmacological and Psychotherapeutic Interventions for Management of Obsessive-compulsive Disorder in Adults: A Systematic Review and Network Meta-analysis. FOCUS The Journal of Lifelong Learning in Psychiatry. 19(4). 457–467. 4 indexed citations
2.
López-López, José A, Jonathan A C Sterne, Howard Thom, et al.. (2017). Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ. 359. j5058–j5058. 381 indexed citations breakdown →
4.
Welton, Nicky J., Alexandra McAleenan, Howard Thom, et al.. (2017). Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 21(29). 1–236. 103 indexed citations
5.
Bryden, Peter, et al.. (2016). Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales. Value in Health. 19(5). 614–622. 15 indexed citations
6.
Skapinakis, Petros, Deborah M Caldwell, William Hollingworth, et al.. (2016). Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. The Lancet Psychiatry. 3(8). 730–739. 239 indexed citations
7.
Skapinakis, Petros, Deborah M Caldwell, William Hollingworth, et al.. (2016). Quality assessment of trials.
8.
Skapinakis, Petros, Deborah M Caldwell, William Hollingworth, et al.. (2016). A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive–compulsive disorder in children/adolescents and adults. Health Technology Assessment. 20(43). 1–392. 87 indexed citations
9.
Howarth, Emma, Theresa HM Moore, Nicky J. Welton, et al.. (2016). IMPRoving Outcomes for children exposed to domestic ViolencE (IMPROVE): an evidence synthesis. SHILAP Revista de lepidopterología. 4(10). 1–342. 67 indexed citations
10.
Bryden, Peter, Nicky J. Welton, Howard Thom, et al.. (2015). A Cost-Effectiveness Analysis Of Novel Oral Anticoagulants For Acute Treatment And Secondary Prevention Of Venous Thromboembolic Disease. Value in Health. 18(7). A390–A390. 1 indexed citations
11.
Woods, Beth, Lisa M. Hess, Joseph Treat, et al.. (2015). Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S.. Lung Cancer. 89(3). 294–300. 17 indexed citations
12.
Simpson, Emma, Sarah Davis, Praveen Thokala, et al.. (2015). Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective. PharmacoEconomics. 33(11). 1187–1194. 11 indexed citations
14.
Bryden, Peter, Deborah M Caldwell, Nicky J. Welton, et al.. (2014). Network Meta-Analysis of the Relative Efficacy of Pharmacological and Psychological Interventions in Adults with Obsessive Compulsive Disorder. Value in Health. 17(7). A454–A455. 1 indexed citations
16.
Bryden, Peter, Hany El Naggar, & Arun J. Valsangkar. (2014). Soil-Structure Interaction of Very Flexible Pipes: Centrifuge and Numerical Investigations. International Journal of Geomechanics. 15(6). 31 indexed citations
17.
Quigley, Joan, Beth Woods, J.C. Thompson, Peter Bryden, & David A. Scott. (2013). Confronting Heterogeneity: Using Systematic Review Effectively for Meta-Analysis. Value in Health. 16(7). A612–A612. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026